Table 1.
Summarized findings of the present study
Fetal |
Adult |
|||
---|---|---|---|---|
Finding | Normoxic* | Hypoxic | Normoxic* | Hypoxic |
PKC-induced contractility | + | + | ++ | +++ |
ERK1/2 inhibition-mediated increase in PKC-induced contractility | + | + | + | − |
Basal PKC | ++ | ++ | ++ | +++ |
Activated PKC | ++ | ++ | ++ | + |
PKC-induced total ERK1/2 phosphorylation | +++ | +++ | +++ | +++ |
PKC-induced ERK1 phosphorylation | + | + | +++ | + |
PKC-induced ERK2 phosphorylation | ++ | +++ | ++ | + |
ROCK inhibition-mediated decrease in PKC-induced contractility | + | − | − | − |
PKC-induced MLC20 phosphorylation sustainability | 5 min | 2 min | 5 min | 2 min |
PKC-induced CPI-17 phosphorylation* | − | − | + | + |